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Missensemutations of the gene encoding NLRP3 are
associated with autoinflammatory disorders charac-
terized with excessive production of interleukin-1b
(IL-1b). Here we analyzed the immune responses of
gene-targeted mice carrying a mutation in the Nlrp3
gene equivalent to the human mutation associated
with Muckle-Wells Syndrome. We found that anti-
gen-presenting cells (APCs) from such mice pro-
duced massive amounts of IL-1b upon stimulation
with microbial stimuli in the absence of ATP. This
was likely due to a diminished inflammasome activa-
tion threshold that allowed a response to the small
amount of agonist. Moreover, the Nlrp3 gene-tar-
getedmiceexhibitedskin inflammationcharacterized
by neutrophil infiltration and a Th17 cytokine-domi-
nant response, which originated from hematopoietic
cells. The inflammation of Nlrp3 gene-targeted mice
resulted from excess IL-1b production from APCs,
which augmented Th17 cell differentitation. These
results demonstrate that the NLRP3 mutation leads
to inflammasome hyperactivation and consequently
Th17 cell-dominant immunopathology in autoinflam-
mation.
INTRODUCTION
The innate immune system provides a first-line defense in the
host’s resistance to invasion by microbial pathogens. In doing
so it relies on evolutionarily conserved germline-encoded recep-
tors called pattern-recognition receptors (PRRs) that sense
conservedmotifs present onmicrobes named pathogen-associ-
ated molecular patterns (PAMPs). After such recognition, the
PRRs initiate rapid responses such as production of proinflam-
matory cytokines and type I interferons, i.e., immune elements
that can affect the initial eradication of pathogenic invaders. In
addition, the PRRs enhance the ability of the adaptive immune
system in the induction of long-lasting pathogen-specific immu-
nity (Franchi et al., 2009; Kumar et al., 2009; Ogura et al., 2006).
So far at least three families of PRRs have been identified and
shown to be activated in response to various microorganisms.860 Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc.These are the Toll-like receptors (TLRs), the helicase retinoic
acid-inducible gene I (RIG-I)-like receptors (RLRs), and NLR
(nucleotide-binding domain and leucine-rich-repeat-containing)
receptors (Kumar et al., 2009; Ting et al., 2008).
The NLR family of proteins usually contains three domains: an
N-terminal protein interaction domain such as caspase recruit-
ment and activation domain (CARD) or pyrin domain (PYD); an
intermediary nucleotide-binding domain (NOD); and aC-terminal
leucine-rich-repeat (LRR) domain (Ting et al., 2008; Yu and Fin-
lay, 2008). A subset of NLRs respond not only to PAMPs, but
also to endogenous danger or stress signals (danger-associated
molecular patterns, DAMPs) such as uric acid and form
a complex with pro-caspase-1 and ASC (apoptosis-associated
speck-like protein containing a CARD) (Franchi et al., 2009; Yu
and Finlay, 2008). Tschopp group first named this caspase-1
activating complex the inflammasome (Martinon et al., 2002).
To date, the NLRP3 inflammasome is one of the best studied
inflammasomes.Uponactivationbymicrobial- or danger-associ-
ated molecular patterns directly or indirectly, NLRP3 and ASC
interact through their respective pyrin domains and subse-
quently,ASCandpro-caspase-1 interact through their respective
CARD domains. This results in the conversion of pro-caspase-1
to active caspase-1 followed by caspase-1-mediated cleavage
of pro-interleukin-1b (IL-1b) and pro-IL-18 to form mature IL-1b
and IL-18.Both of thesecytokinesare highlypotent proinflamma-
tory cytokines involved in host responses to infection and injury
as well as Th17 and Th1 cell differentiation from naive T cells
together with other essential factors (Ogura et al., 2006; Sutton
et al., 2006). Thus, the NLRP3 inflammasomeprovides a platform
for the processing of IL-1b and IL-18 that allows the release of
these cytokines at a site of inflammation and also potentially
creates a microenvironment for Th17 and Th1 cell differentiation
(Ogura et al., 2006; Yu and Finlay, 2008).
Although normal activation of the NLRP3 inflammasome
contributes to host defense, excessive activation leads to inflam-
matory diseases mediated by proinflammatory cytokines in-
cluding IL-1b. This is shown by the fact that mutations in the
human NLRP3 gene are associated with various autoinflamma-
tory disorders such as Muckle-Wells syndrome (MWS), familial
cold autoinflammatory syndrome (FCAS), and chronic infantile
neurologic cutaneous and articular syndrome (CINCA). These
diseases are marked by skin, joint, and eye inflammation as
a result of greatly increased IL-1b production (Dinarello, 2007;
Gattorno et al., 2007). Study of patients with these mutations
or animals with similar mutations offers the opportunity to
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some activation.
In the present study we generated a mouse strain expressing
a R258W mutation in the Nlrp3 gene (NLRP3-R258W), which is
corresponding to the R260W mutation in the human NLRP3
gene associated with one of the autoinflammatory syndromes,
Muckle-Wells syndrome (Neven et al., 2004). These NLRP3-
R258W mice exhibited inflammasome hyperactivation and
developed autoinflammatory disease similar to that in humans.
Importantly, inflammation in such mice was dominated
by Th17 cytokine responses that have the potential to amplify
the inflammation caused by initially excessive inflammasome
activation.
RESULTS
Macrophages from Nlrp3-Mutated Mice Secrete IL-1b
and IL-18 upon TLR Stimulation in the Absence of ATP
To analyze the immunologic response of inflammasome activa-
tion, we created a mouse model of the human Muckle-Wells
syndrome by generating gene-targeted mice bearing a gene
encoding the R258W mutation in NLRP3 (NLRP3-R258W)
(Figure S1 available online). As expected, we found that cells
from these Nlrp3 gene-targeted mice express normal amounts
of NLRP3 under both resting and stimulated conditions
(Figure S1). However, although resting bone marrow-derived
macrophages (BMDM) from NLRP3-R258W mice did not
secrete detectable amounts of IL-1b or IL-18, they did secrete
large amounts of these cytokines upon TLR stimulation, both
in the presence and absence of exogenous ATP. This pattern
differed from that of WT BMDM, which secreted substantial
amounts of IL-1b or IL-18 in the presence but not in the
absence of ATP upon TLR stimulation (Figure 1A; Figure S2A).
A similar result was obtained with bone marrow-derived
dendritic cells (BMDC) and splenic CD11b+ cells (Figures S2B
and S2C).
In further studies involvingmRNA analysis, it was revealed that
transcription of pro-IL-1bwas comparable between lipopolysac-
charide (LPS)-stimulated NLRP3-R258W (R258W) and WT
macrophages (data not shown). However, in immunoblotting
studies, we found that pro-IL-1b processing and mature IL-1b
production fromR258WBMDM took place upon LPS stimulation
both in the presence and absence of ATP, whereas that fromWT
cells occurred only with an ATP pulse (Figure S2D). Similarly,
mature caspase-1 P20 and P10 were generated in stimulated
R258W cells when cultured in the presence or absence of ATP,
whereas WT BMDM produced these active fragments only in
the presence of exogenous ATP (Figure 1B). These results
were confirmed by anti-caspase-1 P10 immunoprecipitation
studies which showed that stimulated BMDM from NLRP3-
R258W but not WT mice secreted caspase-1 P10 (Figure S2E).
Finally, in contrast to production of IL-1b and IL-18, NLRP3
inflammasome-independent proinflammatory cytokine secre-
tion (i.e., IL-12, IL-6, TNF-a, and IL-10 secretion) by R258W
and WT cells was entirely equivalent (Figure S3).
Taken together, these results indicated that the NLRP3 inflam-
masome of R258W-mutated cells were hyperactive and that
mature IL-1b was produced upon TLR ligand stimulation in the
absence of exogenous ATP.Altered Requirement for K+ Efflux and Panx1 Activity
in Activation of the NLRP3-R258W Inflammasome
A possible mechanism of ATP-independent inflammasome acti-
vation of NLRP3-R258W cells arises from recent work showing
that NLRP3 inflammasome activation is dependent on intracel-
lular potassium (K+) depletion triggered by exogenous ATP (Pet-
rilli et al., 2007). We therefore tested whether LPS-stimulated
R258W macrophages exhibited K+ efflux in the absence of
ATP. Whereas 50 mM KCl incubation (sufficient to inhibit potas-
sium efflux without affecting cell viability, data not shown)
completely abolished secretion of IL-1b by WT macrophages
stimulated by LPS in the presence of ATP, it had no effect on
LPS-stimulated R258W macrophages (Figure 1C). Therefore,
production of IL-1b from NLRP3-R258W macrophage in the
absence of ATP was not due to spontaneous potassium efflux.
Other possible mechanisms of ATP-independent inflamma-
some activation of NLRP3-R258W cells is that the mutation
affects the amount of endogenous ATP produced by cells and
the ability of ATP to affect PAMPs (pathogen-associated molec-
ular patterns) entry into cells via pore formation (Kanneganti
et al., 2007; Piccini et al., 2008). In initial studies, we found that
extracellular ATP concentration measured in culture fluids of
R258W and WT macrophages at various times after LPS stimu-
lation and LPS entry to NLRP3-R258W or WT macrophages
were essentially equivalent (data not shown). Thus, the mutation
does not confer ATP independence by affecting the production
of extracellular endogenous ATP.
To study the effect of the mutation on ATP-dependent pore
formation, we next determined the effect of a pannexin-1
(Panx1)-inhibiting peptide (10panx1) (Pelegrin and Surprenant,
2006) on IL-1b secretion by WT and R258W macrophages. We
found that incubation of LPS-stimulated WT macrophages with
either a low (1 mM) or a high (4 mM) concentration of 10panx1
for 30 min to 24 hr prior to an ATP pulse led to clearly reduced
IL-1b production as compared to macrophages subjected to
ATP addition in the absence of 10panx1 (Figure 1D). The reduced
(but not absent) IL-1b production byWT cells in the face of Panx1
inhibition is likely to be due to residual channel function or non-
channel cellular entry of LPS that is still dependent on ATP. In
contrast, incubation of LPS-stimulated R258W macrophages
with 10panx1 for 30 min to 4 hr prior to adding ATP had no effect
on IL-1b production and only preincubation with 10panx1 for 24
hr led to reduced IL-1b production (Figure 1D); in addition, at
all time points the effect of Panx1 inhibition on IL-1b secretion
(or lack thereof) was independent of the presence of exogenous
ATP, even at the 24 hr point that led to reduced IL-1b secretion.
The latter was not due to inhibitor toxicity as shown by the fact
that IL-6 secretion was not affected by preincubation for any
length of time (Figure S4A). Instead, it is again likely to be due
to residual activity of the pannexin-1 channel or nonchannel
entry, which in the case of NLRP3-R258W cells (but notWT cells)
can be mediated by the low amounts of endogenous ATP
released upon LPS stimulation. This is supported by the finding
that R258Wmacrophages stimulatedwith LPS (in the absence of
exogenous ATP) in the presence of an ATP-hydrolysing enzyme,
apyrase, or antagonists of P2X7 receptors such as KN-62 or 2
0,
30-O-(2,4,6-trinitrophenyl)-ATP (TNP-ATP) (Atarashi et al., 2008;
Piccini et al., 2008) exhibit reduced IL-1b secretion, suggesting
that endogenous ATP does indeed play a role in entry of PAMPsImmunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc. 861
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NLRP3 Mutation Potentiates Th17 Cell ResponsesFigure 1. The Inflammasome of NLRP3-R258W BMDM Is Activated in the Absence of ATP Independent from K+ Efflux because of a Lowered
Activation Threshold
(A) BMDM from NLRP3-R258W and WT mice were stimulated with TLR ligands for 24 hr and pulsed with ATP for 1 hr before harvesting where indicated. Mature
IL-1b in culture supernatants was measured with ELISA.
(B) Immunoblotting analysis of NLRP3-R258W and WT BMDM lysates for detection of pro- and mature caspase-1. Lysates of cells without any treatment, ATP
pulse (30 min) only, or LPS priming (4 hr) alone were included as controls.
(C) ELISA measurement of IL-1b release from supernatants of NLRP3-R258W and WT BMDM stimulated with LPS as in (A), 50 mM KCl was incubated together
with LPS for 24 hr to inhibit K+ efflux.
(D) As in (C), with indicated amounts of Panx1-blocking peptide (10panx1) added at various time points before ATP pulse.
(E) As in (C), except that cells were stimulated with various amounts of LPS as indicated.
(F) As in (B), except that cells were stimulated with high (5 mg/ml) or low (0.1 mg/ml) amount of LPS overnight in the presence or absence of ATP pulse.
Data shown represent four (A, B), three (C, E), or two (D, F) independent experiments. ELISA results (A, C, D, E) are shown as mean ± SD.into R258W macrophages (Figure S4B). Overall, we conclude
that because inhibition of the Panx1 channel does not alter the
independence of NLRP3-R258W cells from exogenous ATP,862 Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc.the latter is not due to an effect of the mutation on Panx1-
mediated PAMPs entry into the cell. In addition, because inflam-
masome activation is decreased upon maximal pannexin-1
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does play a role in inflammasome activation in these cells,
possibly via Panx1 activation and entry of small amounts of
PAMPs induced by low amounts of endogenous ATP.
The Inflammasome of NLRP3-R258W Cells
Has a Decreased Activation Threshold
The above results suggested that cellular entry of low amount of
PAMPs was sufficient to activate the R258W inflammasome but
not theWT inflammasome, consistent with recent work suggest-
ing that the mutation might have resulted in a conformation
change in NLRP3 (Aksentijevich et al., 2007) that lowers its
activation threshold. To test this possibility, we determined the
ability of various concentrations of LPS to stimulate BMDMs
from R258W or WT mice to produce IL-1b. As expected, LPS-
stimulated NLRP3-R258W BMDM produced substantial
amounts of IL-1b in the absence of ATP even at a low LPS
dose (Figure 1E). In contrast, in the absence of ATP, WT cells
produced IL-1b only when stimulated with high concentrations
of LPS (R500 ng/ml), and the amount of IL-1b produced by
WT BMDMs at these concentrations was much less than that
produced by R258W BMDMs (Figure 1E). A similar result was
obtained with an immunoblotting study, wherein in the absence
of ATP, R258W cells secreted mature IL-1b upon stimulation
with either high (5 mg/ml) or low (0.1 mg/ml) amount of LPS,
whereas WT cells responded only to high amounts of LPS,
with the secretion of relatively low amount of IL-1b (lane 1)
(Figure S4C). In addition, caspase-1 immunoblotting studies
also demonstrated that LPS alone either at high or low concen-
tration was sufficient to trigger caspase-1 activation in NLRP3-
R258W macrophages in the presence or absence of ATP,
whereas in the case of WT cells, low concentration of LPS could
not induce caspase-1 activation unless ATP was added, even
though high amount of LPS was able to activate caspase-1
from WT cells in the absence of ATP (lane 1) (Figure 1F). We
therefore conclude that in the absence of exogenous ATP, the
inflammasome of NLRP3-R258W cells respond to low amounts
of ligand compared to WT cells because of a lower threshold
of NLRP3 inflammasome activation.
Nlrp3-Mutated Mice Develop Skin Inflammation
and Associated Cellular Infiltration of Lymphoid Tissue
Most NLRP3-R258W mice raised under pathogen-free condi-
tions displayed decreased linear growth and weight gain as
well as hair loss (Figures S5A and S5B and data not shown).
Some of the R258W mice died before weaning and only few of
those that matured generated offspring. This lack of reproduc-
tive capacity was associated with development of dermatitis
affecting the ears, top of the head, and the tail base areas at 8
to 16 weeks of age (Figure S5C) that was accompanied by the
development of enlarged spleen, cervical, axillary, and inguinal
nodes draining areas of dermatitis as well as hepatomegaly
(Figure S5D).
Histologic study of the affected skin of NLRP3-R258W mice
showed marked thickening and heavy neutrophil infiltration in
both epidermis and dermis (Figure 2A). In addition, the lymph no-
des showed loss of germinal center architecture, poorly devel-
oped follicles, expanded interfollicular regions, and a diffuse
neutrophil infiltration, whereas the spleen contained expandedred pulp areas filled with neutrophils and islands of trilineage
hematopoietic cells (Figure 2B). Finally, the liver of NLRP3-
R258Wmice with skin inflammation exhibited a marked periduc-
tal leukocyte infiltration (Figure 2C). Flow cytometric study of
whole cell populations from lymph node and spleen tissues with
neutrophil-specific antibodies (7-4Ag and Ly6G) revealed that
spleen and to a lesser extent lymph node from inflamed R258W
mice contained increased numbers of neutrophils (Figure 2D);
similarly, stainingof tissueswith anti-Gr-1andanti-F4-80showed
that R258W spleen and to a lesser extent lymph node and liver
contained increased numbers of granulocytes andmacrophages
(Figures S5E–S5G). These observations indicate that the sponta-
neous skin inflammation and its associated lymphoid component
is characterized by a prominent ‘‘acute’’ inflammatory infiltration
of neutrophil, granulocytes, and macrophages.
Complete blood cell counts of inflamed NLRP3-R258W mice
were elevated and thus compatible with the presence of inflam-
mation. R258W mice without inflammation have comparable
number of cells with WT control, so the myeloid cell number
increase was most likely secondary to the inflammatory status
of R258W mice (Table S1). In addition, autoantibody titer (anti-
dsDNA) was increased in the blood of NLRP3-R258W mice as
compared with WT mice, but the degree of increase did not
correlate with the extent of inflammation: young R258W mice
without skin inflammation showed similar titers of anti-dsDNA
as R258W mice with severe inflammation (Figure S6). Interest-
ingly, kidney, lung, and gut of NLRP3-R258W mice were free
of inflammation; serum inflammatory cytokine concentrations
of R258W mice was equivalent to those of WT mice; and body
temperature of inflamed R258W mice was almost comparable
to that of WT control (data not shown).
Spontaneous Skin Inflammation in NLRP3-R258W Mice
Is Characterized by a Th17 Cytokine Predominance
To understand further the spontaneous inflammation occurring
in Nlrp3-mutated mice, we determined the cytokine profile of
skin tissues from R258W and WT mice by real-time RT-PCR.
Normal (uninflamed) skin of R258Wmice contained low amounts
of transcript for cytokines and factors such as IL-12p40, IL-1b,
IL-6, IL-17A, IFN-g, RORgt, and T-bet, which were equivalent
to that in WT skin (data not shown). In contrast, in the skin tissue
of inflamed NLRP3-R258W mice, transcript of proinflammatory
cytokines such as IL-12p40, IL-12p35, IL-23p19, IL-1b, IL-6,
and TNF-a were substantially higher than in WT skin (Figure 3A);
in addition, expression of various Th17 cell-related cytokines and
factors such as IL-17A, IL-17F, IL-21, TGF-b1, IL-23 receptor
(IL-23R), RORgt, and IL-22 (the latter a Th17 cytokine involved
in psoriatic skin inflammation) (Zheng et al., 2007) were all
substantially increased (Figure 3A). However, the inflamed skin
of R258Wmicemanifested a poor Th1 cell response: the expres-
sion of NLRP3-R258W tissue IFN-gwasmuch lower than IL-17A
or even undetectable in some experiments, albeit on average still
higher than IFN-g in WT tissue. In addition, it should also be
noted that although tissue IL-12Rb1 expression from R258W
and WT mice were similar, expression of T-bet and IL-12Rb2
were clearly decreased in R258W lesional tissue, and the
decrease of IL-12Rb2 was even greater than that of T-bet
(Figure 3A). Finally, although the IL-4 expression was increased
in inflamed skin of NLRP3-R258W mice, that of IL-5 andImmunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc. 863
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suggesting that a typical Th2 cell response was not present
and the increased amount of IL-4 in R258W tissuewas originated
most likely from mast cells or basophils rather than T cells (Pou-
liot et al., 2005). Overall, these data indicate that the sponta-
neous skin inflammation of NLRP3-R258W mice is associated
with a Th17 cell-skewed cytokine response.
CD4+ T Cells from NLRP3-R258W Mice Exhibit
Increased Activation and IL-17 Production
The Th17 cytokine-dominant profile in inflamed skin tissue of
R258W mice prompted us to examine responses of T cells
from their lymphoid tissues. We found that CD4+ T cells isolated
from lymph nodes and spleens of ‘‘inflamed’’ NLRP3-R258W
mice (mice with active skin lesions) exhibited an activated
phenotype (CD25hi, CD69hi, CD44hi, and CD62Llo) (Figure S7)
and produced considerably more IL-17 and to a lesser extent
IFN-g and IL-4 than WT cells (Figure 3B; Figure S8). These
data correlated with the fact that RORgt expressison was greatly
upregulated in NLRP3-R258W CD4+ T cells whereas T-bet and
GATA-3 expression was only slightly increased as compared
to WT cells (Figure 3C). Thus, CD4+ T cells from inflamed
R258W mice were preactivated in vivo and exhibited a Th17
cell phenotype.
Figure 2. NLRP3-R258W Mice Exhibited
Spontaneous Skin Inflammation
(A) H&E staining of skin tissue from inflamed
NLRP3-R258W or WT mice. Top, ear epidermis
and dermis of R258Wmice are thickened because
of inflammatory cell infiltration; in the severe case
(top left), the hypertrophic epidermis is intermit-
tently eroded by infiltrated cells. Bottom, high
magnification of selected areas from upper panel
showing that infiltrated cells in the NLRP3-
R258W tissue are mainly neutrophils.
(B) Histologic analysis of cervical lymph node and
spleen tissues of NLRP3-R258W or control mice.
GC, germinal center; RP, red pulp; WP, white pulp.
(C) H&E staining of liver from inflamed NLRP3-
R258W or WT mice. Livers from R258W mice
showed marked leukocyte infiltration (arrowhead)
in the protal areas (pv, protal vein), which resulted
in loss of typical bile duct (bd) structure.
(D) Flow cytometry of total cells from lymph nodes
and spleen of NLRP3-R258W and WT mice upon
neutrophil-specific staining with two different anti-
bodies as indicated. Filled peak, WT; solid line,
NLRP3-R258W.
Data represent three independent experiments.
DTH Responses Were Increased in
Nlrp3-Mutated Mice and Displayed
a Th17 Cell Dominant Profile
Previous studies revealed that the NLRP3
inflammasome was activated during
delayed-type hypersensitivity (DTH), a
Tcell-mediatedcellular immune response
to repeated epicutaneous exposure to
contact antigens (Sutterwala et al., 2006;
Watanabe et al., 2007). In accord with
those results, we found that in 1-chloro-2, 4-dinitrobenzene
(DNCB)-induced contact hypersensitivity, young R258W mice
without spontaneous inflammation showed greater DTH
responses than did WT mice, characterized by greater ear
swelling, thickening of epidermis and dermis, as well as heavier
tissue infiltration of neutrophils and monocytes (Figure 4A and
data not shown). Importantly, the cytokine profile in this induced
inflammation was similar to the spontaneous dermatitis devel-
oped in NLRP3-R258W mice. In particular, mRNA encoding
Th17 cell-related cytokines and factors such as IL-17A,
IL-17F, IL-23p19, IL-23R, RORgt, and IL-22 were all elevated
in skin tissue of R258W mice as compared to that of WT mice
that did develop DTH inflammation (Figure 4B). In contrast, tran-
scription of Th1-related cytokines and factors such as IFN-g,
IL12Rb1, T-bet, and IL-12p40 in DTH tissues of R258W and
WT mice were equivalent. In addition, although IL-12p35
expression was higher in NLRP3-R258W tissue, its receptor,
IL-12Rb2, was strongly downregulated (Figure 4B). Finally,
expression of Th2-related cytokines and factors IL-4, IL-5,
and GATA-3 was weaker in DTH tissue of R258W mice than in
WT mice.
In view of the predominance of the Th17 cytokine response
in the DTH inflammation in NLRP3-R258W mice, we also
determined levels of Th17 cell-inducing cytokines. It is864 Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc.
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(A) Real-time RT-PCR analysis for indicated cytokines and factors of RNA from ears of NLRP3-R258W mice that developed spontaneous inflammation or WT
mice, asterisk indicates statistical significance compared to WT as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
(B) Flow cytometry of intracellular staining of IL-17 and IFN-g from lymph node CD4+ T cells of inflamed NLRP3-R258W and WT mice upon activation with PMA
plus ionomycin; numbers indicate the percentage of IL-17- and IFN-g-positive cells.
(C) Real-time RT-PCR analysis of indicated transcription factors in RNA extracted fromCD4+ T cells from spleens of NLRP3-R258Wmice with inflammation orWT
mice; asterisk indicates statistical significance in comparison to WT as follows: **p < 0.01.
Data shown are mean ± SD (A, C) from a representative of four (A) or two (B, C) independent experiments.noteworthy that although IL-1b and to a lesser extent TGF-b1
and TNF-a were elevated in R258W mice as compared to
WT mice, IL-6 and IL-21 expression were almost equal
(Figure 4B). These data suggest that IL-1b was in fact the
main factor resulting in the elevated IL-17 production in the
contact hypersensitivity from R258W mice. Finally, CD4+
T cells in lymph nodes draining the DTH site of R258W mice
produced twice as much IL-17 than controls but secreted
similar amount of IFN-g (Figure 4C). Thus, consistent with
spontaneous inflammation, NLRP3-R258W CD4+ T cells were
also skewed to Th17 cell differentiation in DNCB-induced
inflammation.The Inflammation of NLRP3-R258W Mice Arise
from Abnormalities of Hematopoietic Cells
The above results suggested that the inflammation of R258W
mice was most likely originated from hematopoietic cells that
were capable of producing those cytokines. To confirm this
possibility, we created bone marrow chimeric mice by transfer
of bone marrow cells from either NLRP3-R258W or WT mice to
lethally irradiatedWT recipient mice. Eight weeks after cell trans-
fer, BMDMs from R258W-WT chimeric mice produced IL-1b
upon stimulation with various TLR ligands in the absence of
ATP as did NLRP3-R258W BMDMs in earlier experiments
(Figures 5A, 5B, and 1A). This correlated with the fact that 40%Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc. 865
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NLRP3 Mutation Potentiates Th17 Cell ResponsesFigure 4. Th17Cell-Related Cytokines Are Dominant in Delayed Type Contact Hypersensitivity Inducedwith DNCB fromNLRP3-R258WMice
(A) H&E staining of ear tissue from NLRP3-R258W andWTmice that developed inflammation upon DTH induction with DNCB. Top, ear epidermal of both R258W
andWTmice are thickened because of cell infiltration. Bottom, highmagnification of selected areas from top panel showing that NLRP3-R258W tissue wasmore
heavily infiltrated with neutrophils.
(B) Real-time RT-PCR analysis for indicated cytokines and factors from inflamed ears of NLRP3-R258W and WT mice described in (A), asterisk indicates statis-
tical significance in comparison to WT as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
(C) Flow cytometry of lymph node CD4+ T cells from NLRP3-R258W and WT mice that developed contact hypersensitivity as in Figure 3B.
Data shown are mean ± SD (B) from a representative of three independent experiments.866 Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc.
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constitution of WT Mice Resulted in In-
flammasome Hyperactivation and Th17
Cytokine-Dominant Skin Inflammation
(A) ELISA measurement of IL-1b release from
supernatants of BMDM from indicated bone
marrow chimeric mice stimulated with indicated
PAMPs as in Figure 1A.
(B) Immunoblotting analysis of cells mentioned in
(A) for detection of pro- and mature IL-1b as in
Figure 1B.
(C) Real-time RT-PCR analysis for indicated cyto-
kines from inflamed ears of recipient mice
receiving NLRP3-R258W or WT bone marrow
cells, asterisk indicates statistical significance
between the two samples as follows: **p < 0.01;
***p < 0.001.
(D) Flow cytometry of lymph node CD4+ T cells of
mice described in (A) as in Figure 3B.
Data shown are mean ± SD (A, C) from a represen-
tative of two independent experiments.of R258W-WT chimeric mice (but none of the WT-WT mice)
developed skin inflammation similar to that observed in the
NLRP3-R258Wmice mentioned above and consisting of derma-
titis affecting the ears or the tail base areas (Figure S9). This was
accompanied by the development of enlarged lymph nodes
draining the area of dermatitis as well as splenomegaly and
hepatomegaly (Figures S9A and S9B). As in the R258W mice,
the affected skin of R258W-WT chimeric mice exhibited marked
thickening of epidermis and dermis accompanied by a heavy
infiltration of neutrophils; in addition, the liver, spleen, and lymph
node architecture of these mice was similar to that in the R258W
mice (Figures S9C–S9E). Finally, cytokine analysis by RT-PCR
revealed that lesional skin and draining lymph nodes of
R258W-WT chimeric mice contained cell populations producing
elevated amounts of IL-17A and IL-1b, whereas production of
IFN-g was comparable to that in control WT-WT chimeric mice
(Figures 5C and 5D). These results thus provide strong evidence
that the inflammation of NLRP3-R258W mice originated from
hematopoietic cells.
NLRP3-R258W Antigen-Presenting Cells Support WT
Th17 Cell Differentiation
In further studies we focused on the cellular basis of the Th17 cell
bias of the inflammation in the Nlrp3-mutated mice. In initial
studies to determine whether the Th17 cell-dominant phenotype
of CD4+ T cells from R258W mice was due to an intrinsic abnor-
mality in T cell differentiation, we determined cytokine produc-
tion in cultured CD4+ T cells from NLRP3-R258W or WT mice
stimulated in the absence of antigen-presenting cells under
Th1, Th2, and Th17 cell-polarizing conditions. We found that
similar amounts of IL-17, IFN-g, or IL-4 were produced by
R258W and WT cells under each condition (Figure S10) and
thus concluded that the Th17 cell-dominant phenotype in
NLRP3-R258W mice was most likely due to an abnormality in
the antigen-presenting cells.
To test this latter possibility, we then determined cytokine
production by anti-CD3 plus anti-CD28-stimulated WT CD4+T cells cocultured with splenic CD11b+ cells from R258W
(inflamed) or WT mice in the presence or absence of TLR ligands
underTh17cell-polarizingconditions (TGF-b+IL-6).Thepercentage
of IL-17-producing cells generated in cultures containing R258W
CD11b+ cells was substantially higher than in cultures with WT
CD11b+ cells (Figure 6A, left). Conversely, the percentage of cells
producing IFN-gwas clearly lower (Figure 6A, left) and the ratio of
IL-17/IFN-g was substantially higher in cultures containing
R258WCD11b+ cells (Figure 6A, right). Finally, it should be noted
that the same set of stimulated T cells cocultured with splenic
CD11b+ cells from either NLRP3-R258W or WT mice under
Th0, Th1, and Th2 cell conditions gave rise to very low numbers
of IL-17-secreting cells. In addition, the number of IFN-
g- and IL-4-producing cells was decreased in cultures of WT
T cells incubated with R258W CD11b+ cells in comparison with
T cells cocultured with WT CD11b+ cells (Figure S11). These
results suggest that NLRP3-R258W APCs on the one hand
support Th17 cell differentiation after initial induction of the
Th17 cell program by TGF-b and IL-6, and on the other hand
inhibit other forms of T cell differentiation under lineage-specific
conditions.
In further studieswedeterminedwhether the above capacity of
R258Wmacrophages to enhance IL-17 responseswasmediated
by a secreted factor. Accordingly,WTCD4+ T cells were cultured
under Th17 cell conditions in the presence of supernatants
derived from TLR ligand-stimulated or -unstimulated BMDMs.
We found that T cells incubated with R258W BMDM superna-
tants produced clearly higher amounts of IL-17 and lower
amounts of IFN-g (Figure S12A). It was thus obvious that soluble
factor(s) produced by NLRP3-R258W BMDMs can substitute for
macrophages in the enhancement of Th17 cell responses.
In additional studies we determined whether the enhancing
effect of R258W BMDM supernatants required stimulation of
T cells under Th17 cell conditions. We found that under Th0 cell
conditions (culture of cells in the absence of added cytokines),
WT CD4+ T cells cultured with supernatants from either NLRP3-
R258WorWTBMDMs did not produce IL-17 (Figure S13A, upperImmunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc. 867
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R258W BMDM supernatants in the presence of TGF-b led to
a greater IL-17 response than WT BMDM supernatants under
the same conditions, although the overall degree of the IL-17
response was much lower compared to the response under full
Th17 cell conditions (TGF-b+IL-6) (Figure S13A, lower two rows).
The same experiments with BMDC instead of BMDMgave similar
results (Figure S13B). These datamade it clear that the enhancing
effect of R258W APC supernatants requires Th17 cell skewing
conditions, e.g., the supernatants are acting on T cells that have
undergone initial Th17 cell differentiation with TGF-b plus IL-6.
IL-1 Produced by NLRP3-R258W Macrophages
Supports WT Th17 Cell Differentiation
Previous work showing that IL-1b supports Th17 cell differentia-
tion (Kryczek et al., 2007; Sutton et al., 2006) plus the above find-
ings with macrophage supernatants led us to hypothesize that
IL-1b produced by APCs from NLRP3-R258W mice might be
a soluble factor causing increased IL-17 production. To explore
this possibility, we cocultured IL-1 receptor-deficient (Il1r1/)
CD4+ T cells with R258W CD11b+ cells under the same condi-
tions as those described above for WT CD4+ T cells. We found
that the IL-17 production was substantially decreased compared
Figure 6. IL-1 from NLRP3-R258W Macro-
phages Supports WT Naive CD4+ T Cells
Differentiation into Th17 Cells in the Pres-
ence of TGFb and IL-6
(A) Left: Flow cytometric studies of the intracellular
expression of IL-17 and IFN-g from WT CD4+
T cells 4 days after culture in the presence of
splenic CD11b+ cells from NLRP3-R258W or WT
mice at 3:1 (CD4+:CD11b+) ratio with indicated
stimulation. Right: Quantification of results in left
panel depicted as the ratio between percentage
of IL-17- and IFN-g-producing cells in each
sample; asterisk indicates statistical significance
of IL-17/IFN-g between R258W and WT CD11b+
macrophage incubated T cells as follows: **p <
0.01; ***p < 0.001.
(B) Left: As in (A), except that either NLRP3-
R258W (top two rows) or WT (bottom two rows)
splenic CD11b+ cells were incubated with either
WT (first and third rows) or IL-1 receptor 1-defi-
cient (Il1r1/) (second and fourth rows) CD4+
T cells as indicated. Right: Quantification of results
from left panel depicted as IL-17/IFN-g as in (A),
asterisk indicates statistical significance of IL-17/
IFN-g between WT and Il1r1/ CD4+ T cells
incubated with CD11b+ cells from either NLRP3-
R258W (top) or WT (bottom) mice as follows:
*p < 0.05.
Data shown are mean ± SD from a representative
of three independent experiments.
with WT CD4+ T cells under the same
conditions, whereas IFN-g secretion was
increased (Figure 6B, left, upper two
rows). This result is also reflected in the
ratio of IL-17/IFN-g-producing cells,
wherein the Th17 cell skewing is consid-
erably reduced in cultures of Il1r1/
CD4+ T cells (Figure 6B, top right). Similar results were obtained
in cultures of Il1r1/ CD4+ T cells and NLRP3-R258W BMDM
supernatants (instead of CD11b+ cells) comparing to WT CD4+
T cells under same condition (Figure S12B, left, upper two rows).
Finally, it should be noted that coculture of NLRP3-R258W
CD11b+ cells with CD4+ T cells from Il1r1/ mice did not result
in a decrease in the induction of IL-17 (and increase in IFN-g) to
that seen in cocultures of WT CD11b+ cells with Il1r1/ CD4+
T cells (Figure 6B, left, second and fourth rows). In some
contrast, culture of R258W BMDM supernatants with Il1r1/
CD4+ T cells did result in a decrease in IL-17 induction almost
to the level seen with Il1r1/ CD4+ T cells cultured with WT
BMDM supernatant under most conditions (Figure S12B, left,
second and fourth rows). These results suggest that soluble
IL-1b may not be the only factor involved in the shift toward
IL-17 predominant T cell responses induced by R258W APCs.
This factor, however, is not one of the previous Th17 cell-sup-
porting cytokines because addition of IL-6, IL-21, or IL-23 to
cultures did not lead to an increase in IL-17 expression (data
not shown). Membrane-bound factors or cytokines induced by
the NLRP3 inflammasome that present at low concentrations
in APC supernatants and work synergistically with IL-1b seem
to be a more likely possibility.868 Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc.
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Skin Inflammation in NLRP3-R258W Mice
To confirm that the IL-1 induction of Th17 cell proinflammatory
response was driving inflammation in the Nlrp3-mutated mice,
we determined the effect of both anti-IL-1 receptor-1 (IL-1R1)
and anti-IL-17 on pre-existing dermatitis in NLRP3-R258Wmice.
In the anti-IL-1R1 study, we applied IL-1 receptor-1 blocking
antibody or isotype control Ig to R258Wmicewith skin inflamma-
tion by using a previously described protocol with modification
(Amadi-Obi et al., 2007). We found that after 10 days of antibody
treatment, the skin lesions of inflamed R258W mice were mark-
edly improved as compared with mice administered with isotype
control. In particular, the lesions of such treated mice exhibited
less epidermal and dermal thickening as well as decreased infil-
tration of neutrophils and macrophages (Figure 7A). In addition,
real-time RT-PCR analysis to assess cytokine production in the
skin disclosed that anti-IL-1R1 treatment led to decreased
expression of IL-17 as well as other proinflammatory cytokines
such as IL-1b, IL-12p35, and IFN-g (Figure 7B). However,
IL-12p40 and IL-12Rb1 was unchanged and IL-12Rb2 was
increased (Figure 7B). We attribute the decreases in cytokines
other than IL-17 to the general decrease in inflammatory cells
in the skin lesions and the fact that IL-1b itself can induce proin-
flammatory cytokines. Furthermore, we attribute the increase in
IL-12Rb2 expression to a repressive influence (probably exerted
by IL-1b) that we consistently observed in the skin inflammations
in R258Wmice (see Figures 3A and 4B). Finally, a very similar set
of results were obtained when we assessed the effect of IL-1R1
antibody on induced skin inflammation associated with contact
hypersenstivity in young NLRP3-R258Wmice yet free of sponta-
neous skin inflammation. The DTH reaction on the ears of R258W
mice administered with anti-IL-1R1 was greatly reduced com-
pared to that in R258W mice received control Ig. Correspond-
ingly, the skin histology and cytokine profile were consistent
with an attentuated inflammatory reaction (Figures 7C and 7D).
Once again, IL-1b and IL-17 was greatly reduced and IL-12Rb2
expression was increased (Figures 7D).
In further studies to verify that IL-1b-induced IL-17 was a crit-
ical feature of the inflammation developing in the NLRP3-R258W
mice, we administered IL-17A-neutralizing antibody to mice with
skin inflammation as described above. Similar to anti-IL-1R1
treatment, the skin lesions in R258W mice that received anti-
IL-17A were again markedly improved as compared to those
administered with isotype control with respect to skin thickness
and cytokine profile (Figures 7E and 7F). The decreases in cyto-
kines other than IL-17 was probably due to the general decrease
in inflammatory cells in the skin lesions. Once again, although
IL-12Rb1 was decreased, IL-12Rb2 expression was increased
(Figure 7F). Taken together, these anticytokine studies provide
confirmatory evidence that IL-1b is the main cytokine associated
with the skin inflammation developing in NLRP3-R258W mice
and this cytokine is acting through the induction of Th17 cell
response.
DISCUSSION
In this study we analyzed a gene-targeted mouse strain engi-
neered to harbor a point mutation in the gene encoding NLRP3
(R258W) equivalent to that in patients with Muckle-Wells Syn-drome. The mice exhibited increased NLRP3 inflammasome
activity characterized by ATP-independent IL-1b secretion and
development of dermatitis as do patients with this autoinflamma-
torydisorder (Gattorno et al., 2007). Importantly, the spontaneous
and contactant-induced skin inflammation was characterized by
a response strongly skewed to Th17 cytokines that wasmediated
at least in part by dysregulated antigen-presenting cells (APCs)
producing IL-1b. This conclusion was highlighted by the fact
that administration of either anti-IL-1R1 or anti-IL-17A led to
marked resolution of the skin inflammation.
Although the NLRP3 inflammasome of APCs from NLRP3-
R258W mice was hyperactive, it still required TLR stimulation
for activation. Either TLR signaling blockade with neutralizing
antibody or caspase-1 inactivation with specific inhibitors abol-
ished IL-1b production by R258W macrophages. Nevertheless,
NLRP3 activation was more easily triggered in the NLRP3-
R258W cells than in normal cells because it could occur in the
absence of exogenous ATP. We found that such ATP-indepen-
dent activation was not due to abnormalities of ligand entry
into cells, but rather to a lowered activation threshold, whereby
the inflammasome is triggered by low concentrations of ligand
in the absence of exogenous ATP. This conforms to a model in
which the inflammasome containing a mutated NLRP3 more
readily undergoes activation because of a protein conforma-
tional change resulting from the mutation (Aksentijevich et al.,
2007). This lower activation threshold of NLRP3 in the R258W
mice could explain the fact that they were susceptible to sponta-
neous skin inflammation, because the latter was most likely trig-
gered by local trauma and resulting exposure of cells to low
concentrations of TLR ligands that are sufficient to activate the
inflammasome of cells from NLRP3-R258Wmice but not normal
mice.
The fact that Nlrp3 gene-targeted bone marrow transfer to WT
recipient mice resulted in the development of skin inflammation
in the recipient allows us to conclude that the spontaneous skin
inflammation that developed in NLRP3-R258Wmice was largely
due to abnormalities in cells derived from the hematopoietic
system. However, although NLRP3 is predominantly expressed
in APCs such as macrophages, dendritic cells, and neutrophils,
it is also expressed in other cells including keratinocytes and
mast cells (Nakamura et al., 2009; Sutterwala et al., 2006; Wata-
nabe et al., 2007). It is thus possible that the skin inflammation
with neutrophil infiltration observed in NLRP3-R258W mice
was also due, in part, to release of inflammasome-related cyto-
kines from keratinocytes and mast cells (Nakamura et al., 2009).
An important outcome of this study was the observation that in
both spontaneous and contactant-induced skin inflammation,
NLRP3-R258Wmice exhibited a Th17 cell predominant cytokine
profile in affected tissues. In extensive coculture studies to
determine the basis of this profile, we established that the abnor-
mality lies in the antigen-presenting cell rather than in the T cell.
In addition, the coculture experiments revealed that, in accor-
dance with previous work, the skewing could at least in part be
attributed to the excess production of IL-1b (Kryczek et al.,
2007; Sutton et al., 2006; van Beelen et al., 2007; Yang et al.,
2008). Previous studies are in accord with this association
although in some cases they suggest that IL-1b acts at a different
stage of IL-17 induction than that suggested by our study pre-
sented here. In those studies of human cells, augmentation for
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(A) Histologic analysis of ear skin samples from anti-IL-1R1 or isotype control Ab-treated NLRP3-R258W mice carrying spontaneous inflammation. Data shown
are from representative one out of three mice treated in each group.
(B) Tissue samples as in (A) was analyzed with real-time RT-PCR for indicated cytokines and receptors, asterisk indicates statistical significance in comparison to
control Ab-treated mice as follows: *p < 0.05; **p < 0.01.
(C) H&E staining of ear tissues from R258Wmice treated with either anti-IL-1R1 or control Ab that developed inflammation upon DTH induction with DNCB. Data
shown are from representative one out of three mice treated in each group.
(D) The same samples as in (C) analyzed with real-time RT-PCR for indicated cytokines and receptors, asterisk indicates statistical significance in comparison to
control Ab-treated mice as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
(E) H&E staining of ear skin samples from either anti-IL-17- or isotype control Ab-treated R258W mice that carrying inflammation. Data shown are from
representative one out of three mice treated in each group.
(F) The same samples as in (E) analyzed with real-time RT-PCR for indicated cytokines and receptors, asterisk indicates statistical significance in comparison to
control Ab-treated mice as follows: *p < 0.05; **p < 0.01.
Data shown are mean ± SD (B, D, F) from a representative of two independent experiments.870 Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc.
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seen in memory T cells, not in naive T cells, which were the major
cell population studied here (van Beelen et al., 2007; Yang et al.,
2008). In addition, in studies of murine cells, IL-1b appeared to
be playing a role as a substitute for IL-6 (Kryczek et al., 2007)
or needed IL-23 to induce IL-17 expression (Sutton et al.,
2006), whereas in the present study TGF-b and IL-6 incubation
were necessary antecedents to the effect of IL-1b on Th17 cell
differentiation. The view that IL-1b does in fact influence Th17
cell differentiation in association with other perhaps more
primary differentiation factors is supported by studies from
Veldhoen et al. (2006), who also found that IL-1b together with
TNF-a could augment Th17 cell development in association
with TGF-b and IL-6. In addition, Dong and colleagues recently
found that IL-6 induces the expression of IL-1R1 on T cells and
IL-1 upregulates the expression of interferon regulatory factor
4 (IRF4) and RORgt, which enhance Th17 cell differentiation in
the presence of TGF-b and IL-6 (Chung et al., 2009).
In both the tissue inflammation and coculture studies, the
enhanced Th17 cytokine responses was largely accompanied
by decreased IFN-g production. A possible explanation of this
finding derives from previous work showing that IL-1b selectively
inhibits IL-6-activated STAT-1 phosphorylation and thereby
regulates T-bet transcription (Shen et al., 2000). A second expla-
nation derives from our observation that lesional tissue of
NLRP3-R258W mice exhibited downregulation of the IL-12Rb2
and that treatment of mice with anti-IL-1R1 reversed this effect.
It is thus possible that although inflammasome activation may
lead to secondary induction of IL-12p70 and other proinflamma-
tory cytokines, such IL-12p70 cannot induce IFN-g production.
On a related point, although lymph node and splenic CD4+
T cells from inflamed NLRP3-R258W mice also manifested
a Th17 cell skewing, the skewing in this case was rather modest
and the cells also produced increased amounts of IFN-g and IL-4
compared with control cells. We attribute this ‘‘global’’ increase
in cytokine production to the fact that these peripheral cells were
exposed to a mixed cytokine microenvironment, consisted not
only of IL-1b but also other cytokines such as IL-18 and IL-33,
the latter two being involved in stimulating production of IFN-g
and IL-4 from naive T cells, respectively (Nakanishi et al., 2001;
Schmitz et al., 2005).
A major difference between Th17 and Th1 cell-mediated in-
flammation is that the former is associated with neutrophil infil-
tration and the latter with macrophage infiltration (Kroenke
et al., 2008; Steinman, 2008). This correlates with the fact that
in both psoriasis and airway disease models, IL-17 is required
for neutrophil recruitment (Miyamoto et al., 2003; Nograles
et al., 2008). Thus, the heavy neutrophil infiltration in the inflamed
skin tissue of NLRP3-R258Wmice appears to be directly related
to the local predominance of Th17 cytokines, and previous
studies showing that IL-1b was required for neutrophil recruit-
ment can now be attributed to its induction of IL-17 (Hornung
et al., 2008; Miller et al., 2007). Alternatively, IL-17 signaling is
required for optimal IL-1b production and function (Chabaud
et al., 1998; Cheung et al., 2008; Granet et al., 2004; Koenders
et al., 2005). Thus, it is possible that in the autoinflammation
ensuing from a Nlrp3 mutation, the hyperactive inflammasome
leads first to excessive IL-1b secretion and the expansion of
IL-17-secreting cells, and second to IL-17-mediated recruitmentof inflammasome-containing cells such as neutrophils. This
results in a positive feedback loop that ensures an inflammation
with high degree of neutrophil infiltration and tissue damage.
This possibility is supported by the fact that administration of
either anti-IL-1R1 or anti-IL-17 to NLRP3-R258W mice with
skin inflammation led to similar improvement. On this basis, we
would cautiously suggest that anti-IL-17 may be an effective
alternative approach to the treatment of inflammasome-related
disorders.
Two other features of the NLRP3-R258W mice also deserve
mention as possible mechanisms of disease. One is that the
mice exhibited an elevated titer of dsDNA antibody, which raised
the question of whether the mice were prone to the development
of autoimmune disease. Although such autoimmunity doesn’t
seem to be contributing to the skin inflammation, its presence
in NLRP3-R258W mice cannot be ruled out in view of recent
work showing that autoantibodies can induce macrophage acti-
vation in rheumatoid arthritis (Monach et al., 2004). The other
feature is that the fact that R258W mice displayed increased
T cell activation suggests that the inflammasome abnormality
affects T cell homeostasis. Although such activation most likely
reflects the ongoing inflammation (it was not seen inmicewithout
inflammation), it remains possible that homeostatic disturbances
are present in view of recent studies showing that activation of
the inflammasome is associated with necrotic cell death. It is
possible that endogenous proteins resulting from such cell death
trigger autoimmune responses (Willingham et al., 2007).
In conclusion, we have generated a mouse model mimicking
humanMuckle-Wells syndromeand found thatNLRP3 inflamma-
some hyperactivation led to excessive IL-1b secretion and Th17
cell-dominated inflammation. This model therefore predicts that
humanswith autoinflammatory diseasemayalsohaveTh17cyto-
kine-dominated inflammation. These findings may thus lead to
new ways of controlling autoinflammatory diseases.
EXPERIMENTAL PROCEDURES
Mice
NLRP3-R258W gene-targeted mice were generated as described in Supple-
mental Data according to reported mouse Nlrp3 gene sequence (Anderson
et al., 2004). NLRP3-R258W mice as well as age- and gender-matched
C57BL/6 wild-type mice (Jax664) and IL-1 receptor 1-deficient mice (on
C57BL/6 background, Jax3245) were purchased from Jackson Laboratories
(Bar Harbor, ME) and housed in pathogen-free facility. Animal use adhered
to National Institutes of Health Animal Care Guidelines.
Histological Study
Ear, liver, spleen, and cervical lymph nodes were harvested from NLRP3-
R258W or WT mice, part of them was paraffin embedded and sectioned for
H&E staining for inflammation and architecture study, and the rest were
embedded in O.C.T. (Optimal Cutting Temperature, SAKURA) and kept frozen
at 80C followed with sectioning for immunohistochemical staining with
specific antibodies.
Reagents
Recombinant murine M-CSF, GM-CSF, and IL-4 were from Peprotech. Unless
otherwise described, the doses of TLR ligands applied for stimulation were
as follows: PGN (TLR2 ligand, 10 mg/ml; InvivoGen); P3CSK4 (TLR2 ligand,
0.2 g/ml; InvivoGen); PolyI:C (TLR3 ligand, 25 mM; InvivoGen); LPS (TLR4
ligand, 0.2 mg/ml; Sigma-Aldrich); Flagellin (TLR5 ligand, 0.5 mg/ml; InvivoGen);
Loxoribine (TLR7 ligand, 100 mM; InvivoGen); Imiquimod (R837, TLR7 ligand,Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc. 871
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ATP, Apyrase, KN-62, and TNP-ATP were all from Sigma-Aldrich.
ELISA
Concentrations of cytokines frommouse cell culture supernatants were deter-
mined by BD Biosciences ELISA kits for assay of IL-12p40, TNF-a, IL-10, IL-6,
and IFN-g; eBioScience kits for assay of IL-1b, IL-17A, IL-23p19; and R&D
systems kits for assay of IL-12p70, IL-18, and IL-21. Mouse Anti-ds DNA
ELISA kit was from Alpha Diagnostic Intl. Inc.
Immunoblotting and Immonoprecipitation
For NLRP3 expression analysis, BMDM lysis and blotting was performed as
described previously (Meng et al., 2003). The membrane was blotted with
NLRP3 Ab (M-12, sc-34410) (Santa Cruz) and b-Actin Ab (Cell Signaling). For
caspase-1 and mature IL-1b analysis, BMDM was pretreated for 4 hr with
LPS, 5 mM ATP (Sigma) was added, and 30 min later, NP40 (final 1%), DTT
(final 10 mM), as well as protease inhibitors were added to culture medium.
Cells as well as supernatant were collected, nuclei and membranes were
removed via centrifugation, and SDS sample buffer was added before boiling
and analyzing by immunoblotting for caspase-1 as well as cleaved IL-1b with
Abs as follows: Caspase-1 P20 (kind gift from G. Nunez), Caspase-1 P10
(sc-514), and IL-1b (H-153) (Santa Cruz) (Franchi et al., 2007; Pelegrin and
Surprenant, 2006).
Immunoprecipitation (IP) followed by immunoblotting (IB) of caspase-1 P10
was carried out with BMDM culture supernatant with the same antibody
mentioned above.
Cell Isolation, Culture, and Flow Cytometry Analysis
BMDM were prepared as described previously (Spiller et al., 2007). In brief,
bone marrow (BM) cells were cultured in Petri dishes in 10 ml of complete
RPMI medium in the presence of recombinant M-CSF (40 ng/ml). After
3 days of culture, half of the medium was replaced by fresh medium. On day
6, adherent cells were harvested and used as indicated.
For making BMDC, BM cells were prepared from NLRP3-R258W as well as
control mice and cultured in Petri dishes (1 3 106/ml) in 10 ml of complete
RPMI medium supplemented with recombinant GM-CSF (20 ng/ml) and IL-4
(20 ng/ml). After 3 days of culture, half of the medium was replaced by fresh
medium and on day 6 cells were harvested and sorted by anti-mouse
CD11c magnetic beads (Miltenyi Biotech) prior to use in studies of cytokine
secretion or coculture experiments (Watanabe et al., 2008).
Total lymph node and spleen cell staining for infiltrated neutrophils was
carried out with two different antibodies, anti-7-4 antigen (CL8993B, Cedar-
lane labs) and Ly6G (clone 1A8, 551459, BD Biosciences). Splenic macro-
phages were purified via positive selection with anti-CD11b microbeads
(Miltenyi Biotech) from total splenocytes and applied for IL-1b secretion study
or coculture with T cells. CD4+ T cells were purified from lymph nodes and
spleen with microbeads (L3T4, Milteny, Auburn, CA) via magnetic sorting.
These T cells were either stimulated with plate-bound anti-CD3 (10 mg/ml)
and soluble anti-CD28 (2 mg/ml) for 2 days for ELISA study or activated for
4 days with anti-CD3/28 followed by reactivation (PMA+ionomycin, 0.25 mg/ml
each, 5 hr) and intracellular staining for IL-17A, IFN-g, as well as IL-4. Golgi
stop (0.67 ml/ml, BD, 51-2092KZ, 554724) was added 3 hr before cells were
harvested for intracellular staining. CD4+ T cell differentiation was done as
described previously and flow cytometry was with Becton Dickinson FACS
Caliber with Cell Quest program (Zhang and Boothby, 2006).
RT-PCR and Real-Time PCR
Total RNAwas extracted frommice skin or cultured cells with Trizol (Invitrogen)
and cDNA was synthesized with reverse transcription kits (Applied Biosys-
tems) according to manufacturer’s instructions. RT-PCR of exon 3 of Nlrp3
gene from either R258W BMDM RNA or WT control was done with primers
50-GTGAGAGTGTGGACCTCAACAG-30 and 50-GTCCAGGAGATGCTGCAGT
TTC-30. Equal loading was confirmed by simultaneous HPRT amplification.
Cytokine RT-PCR was performed with TaqMan gene expression assays as
well as gene-specific primer and probe settings; data shown are respective
gene expression relative to GAPDH via 2-Dct method (Zheng et al., 2007)
(Supplemental Data).872 Immunity 30, 860–874, June 19, 2009 ª2009 Elsevier Inc.Contact Hypersensitivity
Female mice (6–10 weeks old) were sensitized by topical applicatiion of 20 ml
5% DNCB (Sigma) dissolved in acetone/olive oil solution (4:1) (v/v) to the
shavedmiddle back skin (2 cm2) on day 0. On day 5, all mice were challenged
by topical application of 20 ml of 0.5% DNCB on both sides of both ears. 24 hr
after the irritation, ear samples were taken for either histologic study upon H&E
staining or extraction of RNA for real-time RT-PCR analysis. Spleen and lymph
node T cells were isolated from these DNCB-treated mice for intracellular
staining of IL-17 and IFN-g.
Bone Marrow Reconstitution
Bonemarrow chimeras were generated as describedwithmodification (Zhang
et al., 2009). In brief, recipient C57BL/6 mice were irradiated with one dose of
940 rads at 70 rads/min from a 137Cs source. 2 mg/ml Neomycine sulfate was
given in drinking water 1 day prior to 2 weeks after irradiation. 24 hr after irra-
diation, 23 107 total bone marrow cells from gender-matched NLRP3-R258W
or WT donor mice were injected intravenously into recipients. 4 weeks after
injection, total genomic DNA from 100 ml blood of recipient micewas subjected
to NLRP3-R258W-specific PCR analysis to confirm successful repopulation of
donor cells. 8 weeks after bone marrow transfer, recipient mice were used for
experiments.
IL-17A Neutralization and IL-1 Receptor 1 Blockade
For IL-17 neutralization, anti-IL-17 (MAB421) was applied with Rat IgG2A
(MAB006) as Isotype Control. For IL-1R1 blockade, anti-IL-1R1 (MAB7711)
was applied with Ms IgG1 (MAB002) as control Ig (all these antibodies were
from R&D systems). For intervention of spontaneous inflammation from
NLRP3-R258W mice, antibody was injected intraperitoneally with 100 mg in
200 ml PBS every other day for 5 injections. Two days after the last injection,
mice were sacrificed for analysis. For blockade of DNCB-induced hypersensi-
tivity, the first Ab injection was 2 days before DNCB sensitization, then injected
on day 0 (DNCB sensitization), day 1, day 3, and day 5 (DNCB irritation). Mice
were used for experiment on day 6.
Statistics
Two-tailed Student’s t test was used to evaluate the significance of differences
and p < 0.05 was regarded as statistically significant.
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